Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture

Bio-Medical Materials and Engineering

Volumn 15, Issue 4, 2005, Pages 261-267

  Sonobe, Masato ^a   Hattori, Koji ^b   Tomita, Naohide ^c   Yoshikawa, Takafumi ^b   Aoki, Hideyuki ^a   Takakura, Yoshinori ^b   Suguro, Toru ^a  

^a TOHO UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Bone formation; Bone marrow derived mesenchymal stem cell; Statins

Indexed keywords

BONE; CELLS; DISEASES; ENZYMES; PATIENT TREATMENT;

ALKALINE PHOSPHATASE ACTIVITY; BONE FRACTURES; BONE MARROW; MESENCHYMAL STEM CELLS (MSC); OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS; THERAPEUTIC AGENTS;

ORTHOPEDICS;

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; CONTROLLED STUDY; DRUG EFFECT; FRACTURE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FRACTURE HEALING; FRACTURES, BONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, INBRED F344; TISSUE ENGINEERING;

EID: 22244460553     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. A.W. Alberts, J. Chen, G. Kuron et al., Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent, Proc. Natl. Acad. Sci. USA 77 (1980), 3957-3961.
2. K.A. Chan, S.E. Andrade, M. Boles et al., Inhibition of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older woman, Lancet 355 (2000), 2185-2188.
3. Y. Komatsu, Promotion of bone formation by HMG-CoA reductase inhibitors, statins, The Bone 15 (2001), 311-315 (in Japanese).
4. T. Maeda, A. Matsunuma, T. Kawanae et al., Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells, Biochem. Biophys. Res. Commun. 280 (2001), 874-877.
5. C. Maniatopoulos, J. Sodek and A.H. Melcher, Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats, Cell Tissue Res. 254 (1988), 317-330.
6. G. Mundy, R. Garrett, S. Harris et al., Stimulation of bone formation in vitro and in rodents by statins, Science 286 (1999), 1946-1949.
7. H. Ohgushi, Y. Dohi, T. Katuda et al., In vitro bone formation by rat marrow cell culture, J. Biomed. Mater. Res. 32 (1996), 333-340.
8. H. Ohgushi, Y. Dohi, T. Yoshikawa et al., Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics, J. Biomed. Mater. Res. 32 (1996), 341-348.
9. B.W. Phillips, N. Belmonte, C. Vernochet et al., Compactin enhances osteogenesis in murine embryonic stem cells, Biochem. Biophys. Res. Commun. 284 (2001), 478-484.
10. M. Sugiyama, T. Kodama, K. Konishi et al., Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells, Biochem. Biophys. Res. Commun. 271 (2000), 688-692.
11. P.S. Wang, D.H. Solomon, H. Mogun et al., HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients, JAMA 283 (2000), 3211-3216.
12. T. Yoneda, Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action, Nippon Rinsho 60(Suppl. 3) (2002), 688-695 (in Japanese).
13. T. Yoshikawa, S.A.F. Peel, J.R. Gladstone et al., Biochemical analysis of the response in rat bone marrow cell cultures to mechanical stimulation, Biomed. Mater. Eng. 7 (1997), 369-377.